Gathering more than 10 years of work in the tilapia industry, Phileo by Lesaffre launches a dedicated program aiming to improve gut health and support disease prevention strategies. The Program Aquasaf Tilapia was conceived to maximize productivity, profitability and sustainability of tilapia farming using Phileo’s functional yeast probiotics and postbiotics.
To build the program, Phileo draws on knowledge from more than 10 R&D projects carried out in China, Thailand, Vietnam, Brazil, Mexico, and the Philippines using different products and their combination, both in lab and field conditions.
The program provides science-based recommendations to address some of the most impacting challenges faced by producers such as mortalities caused by bacterial infections from Aeromonas hydrophila and Streptococcus agalactiae, reduced growth associated with oxidative stress, economic losses due to poor gut health and feed conversion, while avoiding the use of antimicrobial and chemical substances.
Tools to support and empower professionals
Otavio Serino Castro, Phileo’s Aquaculture Global Species Manager explains: “We designed Program AquaSaf Tilapia to provide a clear view on the mechanisms of action of our solutions and their benefits on immunity, microbiota and performance in different production conditions. It is a tool to support and empower professionals when developing preventive care strategies for a more sustainable tilapia production”.
Program Aquasaf Tilapia details how Safmannan, Phileo’s yeast postbiotic, can reduce pathogens-related mortalities by up to 50%, and how substantial improvements of feed conversion, growth and fillet yield can be achieved by exploring synergies with other Phileo key brands such as organic selenium-enriched yeast Selsaf, or yeast probiotic Actisaf.
Efficacy in combating seasonal diseases
Tilapia is farmed in many subtropical regions, such as China, Egypt, and Brazil where production is hindered by seasonal diseases, hence specific actions throughout the production cycle are needed.
Alban Caratis, Phileo’s Aquaculture Global Program Manager, highlights that in some areas the issues are likely to grow in complexity due to the continued development and intensification of production, water scarcity, the emergence of antimicrobial-resistant pathogens and climate change.
He also adds: “With the AquaSaf Tilapia program, we aim to demonstrate that our solutions and sustainable practices can deliver improved performances, better profitability and increased animal welfare, whether they are adopted by global tilapia industry players or family farmers. That is part of our vision to act with nature for animal care.”
A complete and free handbook on the company’s solutions
Phileo created a comprehensive manual for tilapia farmers and feed producers detailing guidelines and recent trial results demonstrating the applicability of yeast probiotics and postbiotics for the tilapia industry.
The members of Phileo assures that they daily supports their partners, from global industry players to family farmers, in their transition towards sustainable good practices.
“With them, the company develops tailor-made solutions for preventive care allowing a limited and responsible use of antibiotics by mastering microbiota and immunity.”
“Our shared ambition is to raise healthy animals while sparing planet resources and energy. Our rich collection of proprietary probiotic strains allows us to develop evidence-based solutions taking into account animal species’ diversity ranging from pets, livestock, poultry, fish to insects to overcome the increasing complexity of food production,” they say.
Phileo offers the user manual for download on their website. To download your copy https://phileo-lesaffre.com/en/program-aquasaf-tilapia/